Resource Library

This sample contract playbook includes alternative clauses, required approvals, and negotiation notes.

Contract playbooks help the legal department, executive team, and sales understand which contracts are acceptable and which contracts the company will walk away from. This article walks through the process of creating a contract playbook.

This presentation highlights key results from ACC's 2024 Chief Legal Officers Survey and offers 12 reasons why CLOs need direct access to the CEO and the organization's board.

This blog explores physician recapitalization transactions and how complex they are and their myriad issues. At Foley, in our representation of both investors in, and sellers of, physician practices, we note how often tax issues become gating items that drive the structural aspects of the transaction.

For small teams facing big challenges, automation is a critical tool that increases efficiency and reduces manual errors, freeing up valuable time for more strategic work. Read more here.

While low-code and no-code workflow automation technology solutions are not new, 2023 has brought a distinct shift in legal departments embracing workflow automation. Hyperion Research, an Epiq Company, undertook a benchmarking study revealing that 71% of respondents planned to invest in a workflow automation (WFA) tool in the next 12-18 months either as a first-time investment or to replace an existing WFA tool. Read more here.

In an era dominated by technological advancements, the legal industry has not been immune to the allure of artificial intelligence (AI) and automation. Proponents of AI in legal operations often herald its potential to revolutionize the profession, promising increased efficiency, accuracy, and cost-effectiveness. While AI undoubtedly offers numerous benefits, it is essential to recognize its limitations and acknowledge that technology alone will not solve all the complex issues inherent in legal operations. Read this article to learn more.

Foley & Lardner’s Top Trends for 2024 publication unpacks key developments in an uncertain regulatory landscape.

Since its inception in 1992, the 340B Drug Pricing Program (340B Program) has provided eligible health care providers (covered entities) access to significant discounts on the cost of outpatient pharmaceuticals from participating manufacturers.

Over the past 15 years, the 340B Program’s size and scope has expanded due to actions by Congress and the federal Health Resources and Services Administration (HRSA). This article provides an overview of the program's current state.

This Privacy Capability Maturity Model provides a detailed maturity model for all aspects of an organization’s privacy program, including its use of Artificial Intelligence (AI) and Machine Learning (ML) using personal information.

It seeks to gauge program capability across a variety of program elements, taking a “big picture” view on an organization’s readiness to comply with these requirements.